Prioritizing pricing excellence for sustainable growth in medtech and diagnostics
Discover insights on pricing in medtech and diagnostics from our 2024 Global Pricing Study report. Our experts reveal the latest developments in medtech pricing and the most important actions to consider for better price management in 2024.
In 2024, the medical technology (medtech) and diagnostics sectors must prioritize effective price management to sustain their traditional success.
While both sectors have seen profitable growth in the past, they now face challenges that require pricing innovation in healthcare. The long-term effects of adverse macroeconomic trends are fundamentally reshaping commercial priorities.
Our new Global Pricing Study uncovers critical pricing trends in our ‘State of Pricing’ report, offering insights into navigating these complex market forces. We outline key insights from the report to help both sectors strategize for price optimization toward continued growth.
